{"id":6487,"date":"2023-02-27T22:27:35","date_gmt":"2023-02-27T22:27:35","guid":{"rendered":"\/\/smallcapscn.x5view.co\/?p=6487"},"modified":"2023-08-29T17:57:08","modified_gmt":"2023-08-29T17:57:08","slug":"incannex-commences-phase-2-trial-ihl-675a-treatment-rheumatoid-arthritis","status":"publish","type":"post","link":"https:\/\/smallcapscn.x5view.co\/?p=6487","title":{"rendered":"Incannex \u5f00\u59cb\u8bc4\u4f30 IHL-675A \u6cbb\u7597\u7c7b\u98ce\u6e7f\u6027\u5173\u8282\u708e\u7684 2 \u671f\u8bd5\u9a8c"},"content":{"rendered":"

\u836f\u7528\u5927\u9ebb\u7d20\u548c\u8ff7\u5e7b\u7597\u6cd5\u5f00\u53d1\u5546 Incannex Healthcare (ASX: IHL) \u5df2\u7ecf\u5f00\u59cb\u4e86\u4e00\u9879 2 \u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u4ee5\u8bc4\u4f30\u5176\u4e13\u6709\u6297\u708e\u8054\u5408\u836f\u7269 IHL-675A \u5728\u7c7b\u98ce\u6e7f\u6027\u5173\u8282\u708e\u60a3\u8005\u4e2d\u7684\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\u3002<\/p>\n

\u8be5\u8bd5\u9a8c\u7531 Avance Clinical \u7ba1\u7406\uff0c\u5c06\u5728\u6fb3\u5927\u5229\u4e9a\u548c\u65b0\u897f\u5170\u7684\u591a\u8fbe 10 \u4e2a\u5730\u70b9\u53c2\u4e0e\uff0c\u5171\u62db\u52df 120 \u540d\u60a3\u8005\uff0c\u4f7f\u5176\u6210\u4e3a\u8be5\u884c\u4e1a\u6700\u5927\u7684\u4e34\u5e8a\u8bd5\u9a8c\u4e4b\u4e00\u3002<\/p>\n

\u8be5\u8bd5\u9a8c\u5c06\u5728 24 \u5468\u5185\u5229\u7528\u60a3\u8005\u62a5\u544a\u7684\u7ed3\u679c\u3001\u75be\u75c5\u8bc4\u5206\u548c\u708e\u75c7\u751f\u7269\u6807\u5fd7\u7269\u5206\u6790\u6765\u8bc4\u4f30 IHL-675A \u5bf9\u75bc\u75db\u548c\u529f\u80fd\u7684\u5f71\u54cd\u3002<\/p>\n

\u7b26\u5408\u5173\u8282\u635f\u4f24\u6807\u51c6\u7684\u60a3\u8005\u4e5f\u53ef\u80fd\u88ab\u7eb3\u5165\u78c1\u5171\u632f\u6210\u50cf (MRI) \u8bc4\u4f30\u5b50\u7814\u7a76\u3002<\/p>\n

IHL-675A \u662f\u4e00\u79cd\u4e13\u6709\u7684\u56fa\u5b9a\u5242\u91cf\u7ec4\u5408\u836f\u7269\uff0c\u5305\u542b\u5927\u9ebb\u4e8c\u915a\uff08CBD\uff09\u548c\u7f9f\u6c2f\u55b9\uff08HCQ\uff09\u3002<\/p>\n

HCQ \u88ab\u6279\u51c6\u7528\u4e8e\u6cbb\u7597\u7c7b\u98ce\u6e7f\u6027\u5173\u8282\u708e\uff0c\u5e76\u88ab\u5927\u91cf\u60a3\u6709\u8be5\u75be\u75c5\u7684\u60a3\u8005\u4f7f\u7528\u3002 \u636e\u62a5\u9053\uff0c\u8bb8\u591a\u4eba\u8fd8\u4f7f\u7528\u975e cGMP \u7ea7 CBD \u6765\u6539\u5584\u4ed6\u4eec\u7684\u75c7\u72b6\u3002<\/p>\n

Incannex \u7684\u76ee\u7684\u662f\u5bf9\u5176\u4e13\u6709\u7684 HCQ \u548c CBD \u56fa\u5b9a\u5242\u91cf\u7ec4\u5408\u8fdb\u884c\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u4ee5\u83b7\u5f97\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40\uff08 FDA \uff09\u5bf9\u836f\u7269\u7ea7 IHL-675A \u4ea7\u54c1\u7684\u8425\u9500\u6279\u51c6\uff0c\u60a3\u8005\u7684\u533b\u751f\u53ef\u4ee5\u653e\u5fc3\u5f00\u5904\u65b9 .<\/p>\n

\u5728\u8fdb\u884c\u6b64 2 \u671f\u8bd5\u9a8c\u4e4b\u524d\uff0c\u636e\u62a5\u9053 IHL-675A \u5728 1 \u671f\u8bd5\u9a8c\u4e2d\u5177\u6709\u826f\u597d\u7684\u8010\u53d7\u6027\u3002 \u5728\u52a8\u7269\u7814\u7a76\u4e2d\uff0c\u89c2\u5bdf\u5230 IHL-675A \u6bd4 HCQ \u66f4\u80fd\u964d\u4f4e\u5173\u8282\u708e\u75be\u75c5\u8bc4\u5206\u3002<\/p>\n

\u52a8\u7269\u6a21\u578b<\/h2>\n

\u7c7b\u98ce\u6e7f\u6027\u5173\u8282\u708e\u52a8\u7269\u6a21\u578b\u663e\u793a IHL-675A \u6bd4\u556e\u9f7f\u52a8\u7269\u7b49\u6548\u6807\u51c6\u5242\u91cf HCQ \u66f4\u6709\u6548\u5730\u51cf\u5c11\u708e\u75c7\uff0c\u5305\u62ec\uff1a\u4e34\u5e8a\u8bc4\u5206\u3001\u722a\u4f53\u79ef\u3001\u8840\u7ba1\u7ff3\u8bc4\u5206\u3001\u603b\u7ec4\u7ec7\u5b66\u8bc4\u5206\u548c\u8840\u6e05\u7ec6\u80de\u56e0\u5b50\u6c34\u5e73\u3002<\/p>\n

\u5728\u6807\u51c6\u5242\u91cf\u4e0b\uff0c\u6240\u8fbe\u5230\u7684\u75be\u75c5\u8bc4\u4f30\u51cf\u5c11\u9ad8\u8fbe 3.52 \u500d\u3002<\/p>\n

\u8fd9\u4e9b\u89c2\u5bdf\u7ed3\u679c\u5bfc\u81f4 Incannex \u4f18\u5148\u8003\u8651 IHL-675A \u7684\u5feb\u901f\u4e34\u5e8a\u8bc4\u4f30\uff0c\u7279\u522b\u662f\u8003\u8651\u5230 HCQ \u662f\u4e00\u79cd\u5e38\u89c1\u7684\u957f\u671f\u6cbb\u7597\u7c7b\u98ce\u6e7f\u6027\u5173\u8282\u708e\u7684\u836f\u7269\u3002<\/p>\n

\u5b89\u5168\u6027\u548c\u6709\u6548\u6027<\/h2>\n

Incannex \u9996\u5e2d\u79d1\u5b66\u5b98 Mark Bleackley \u535a\u58eb\u8868\u793a\uff0c\u7b2c\u4e8c\u9636\u6bb5\u8bd5\u9a8c\u5c06\u5bfb\u6c42\u786e\u5b9a IHL-675A \u7684\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\uff0c\u5e76\u4e3a FDA \u7684\u65b0\u836f\u7533\u8bf7\u6863\u6848\u505a\u51fa\u8d21\u732e\u3002<\/p>\n

\u4ed6\u8bf4\uff1a\u201c\u8fd9\u9879\u8bd5\u9a8c\u662f\u6211\u4eec IHL-675A \u5f00\u53d1\u8ba1\u5212\u7684\u4e00\u4e2a\u91cd\u8981\u91cc\u7a0b\u7891\uff0c[\u5e76\u4e14]\u6211\u4eec\u5f88\u9ad8\u5174\u786e\u5b9a\u5728\u5173\u8282\u708e\u52a8\u7269\u75be\u75c5\u6a21\u578b\u4e2d\u89c2\u5bdf\u5230\u7684\u663e\u7740\u4e34\u5e8a\u524d\u7597\u6548\u662f\u5426\u4e5f\u80fd\u5728\u4eba\u7c7b\u8eab\u4e0a\u5f97\u5230\u7c7b\u4f3c\u7a0b\u5ea6\u7684\u4f53\u73b0\u3002\u201d<\/p>\n

\u201c\u5173\u8282\u708e\u662f\u4e00\u79cd\u5bf9\u5168\u4e16\u754c\u6570\u767e\u4e07\u4eba\u7684\u798f\u7949\u4ea7\u751f\u8d1f\u9762\u5f71\u54cd\u7684\u75be\u75c5\uff0c\u8fd9\u9879\u8bd5\u9a8c\u662f\u671d\u7740[\u6211\u4eec]\u8fc8\u51fa\u7684\u4e00\u5927\u6b65\uff0c\u53ef\u80fd\u4f1a\u6539\u5584\u8fd9\u4e9b\u60a3\u8005\u7684\u751f\u6d3b\u8d28\u91cf\u3002\u201d<\/p>\n

\u591a\u7528\u836f<\/h2>\n

IHL-675A \u6b63\u5728\u5f00\u53d1\u4e3a\u9002\u7528\u4e8e\u9884\u9632\u548c\u6cbb\u7597\u708e\u75c7\u7684\u591a\u7528\u9014\u836f\u7269\uff0c\u6700\u521d\u7684\u91cd\u70b9\u662f\u7c7b\u98ce\u6e7f\u6027\u5173\u8282\u708e\u3001\u708e\u75c7\u6027\u80ba\u90e8\u75be\u75c5\uff08\u5305\u62ec\u6025\u6027\u547c\u5438\u7a98\u8feb\u7efc\u5408\u5f81\u3001\u6162\u6027\u963b\u585e\u6027\u80ba\u75c5\u3001\u54ee\u5598\u548c\u652f\u6c14\u7ba1\u708e\uff09\uff1b \u548c\u708e\u75c7\u6027\u80a0\u75c5\u3002<\/p>\n

\u8fd9\u4e9b\u9002\u5e94\u75c7\u7684\u6cbb\u7597\u88ab\u8ba4\u4e3a\u5177\u6709\u6bcf\u5e74\u8d85\u8fc7 1250 \u4ebf\u7f8e\u5143\u7684\u5168\u7403\u5e02\u573a\u89c4\u6a21\u3002<\/p>\n

Incannex \u5df2\u5b8c\u6210\u4e0e FDA \u7684\u7814\u7a76\u524d\u65b0\u836f\uff08IND\uff09\u4f1a\u8bae\uff0c\u8ba8\u8bba IHL-675A \u5728\u7f8e\u56fd\u5f00\u53d1\u7684\u76d1\u7ba1\u9014\u5f84\uff0c\u5e76\u8ba1\u5212\u4e3a\u4e09\u4e2a\u9002\u5e94\u75c7\u4e2d\u7684\u6bcf\u4e00\u4e2a\u5f00\u653e IND \u3002<\/p>\n

HCQ \u5df2\u88ab\u6279\u51c6\u7528\u4e8e\u6cbb\u7597\u7c7b\u98ce\u6e7f\u6027\u5173\u8282\u708e\uff0c\u5e76\u88ab\u5927\u91cf\u60a3\u6709\u8be5\u75be\u75c5\u7684\u8bd5\u9a8c\u60a3\u8005\u4f7f\u7528\u3002<\/p>\n

\u6839\u636e\u4e34\u5e8a\u7ed3\u679c\uff0c\u5982\u679c IHL-675A \u88ab\u8bc1\u660e\u6bd4\u5355\u72ec\u4f7f\u7528 HCQ \u66f4\u6709\u6548\uff0c\u90a3\u4e48 IHL \u53ef\u80fd\u5df2\u7ecf\u4e3a\u7c7b\u98ce\u6e7f\u6027\u5173\u8282\u708e\u60a3\u8005\u627e\u5230\u4e86\u66f4\u597d\u7684\u66ff\u4ee3\u836f\u7269\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"

\u836f\u7528\u5927\u9ebb\u7d20\u548c\u8ff7\u5e7b\u7597\u6cd5\u5f00\u53d1\u5546 Incannex Healthcare (ASX: IHL) \u5df2\u7ecf\u5f00\u59cb\u4e86\u4e00\u9879 2 \u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u4ee5\u8bc4\u4f30\u5176\u4e13\u6709\u6297\u708e\u8054\u5408\u836f\u7269 IHL-675A \u5728\u7c7b\u98ce\u6e7f\u6027\u5173\u8282\u708e\u60a3\u8005\u4e2d\u7684\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\u3002 \u8be5\u8bd5\u9a8c\u7531 Avance Clinical \u7ba1\u7406\uff0c\u5c06\u5728\u6fb3\u5927\u5229\u4e9a\u548c\u65b0\u897f\u5170\u7684\u591a\u8fbe 10 \u4e2a\u5730\u70b9\u53c2\u4e0e\uff0c\u5171\u62db\u52df 120 \u540d\u60a3\u8005\uff0c\u4f7f\u5176\u6210\u4e3a\u8be5\u884c\u4e1a\u6700\u5927\u7684\u4e34\u5e8a\u8bd5\u9a8c\u4e4b\u4e00\u3002 \u8be5\u8bd5\u9a8c\u5c06\u5728 24 \u5468\u5185\u5229\u7528\u60a3\u8005\u62a5\u544a\u7684\u7ed3\u679c\u3001\u75be\u75c5\u8bc4\u5206\u548c\u708e\u75c7\u751f\u7269\u6807\u5fd7\u7269\u5206\u6790\u6765\u8bc4\u4f30 IHL-675A \u5bf9\u75bc\u75db\u548c\u529f\u80fd\u7684\u5f71\u54cd\u3002 \u7b26\u5408\u5173\u8282\u635f\u4f24\u6807\u51c6\u7684\u60a3\u8005\u4e5f\u53ef\u80fd\u88ab\u7eb3\u5165\u78c1\u5171\u632f\u6210\u50cf (MRI) \u8bc4\u4f30\u5b50\u7814\u7a76\u3002 IHL-675A \u662f\u4e00\u79cd\u4e13\u6709\u7684\u56fa\u5b9a\u5242\u91cf\u7ec4\u5408\u836f\u7269\uff0c\u5305\u542b\u5927\u9ebb\u4e8c\u915a\uff08CBD\uff09\u548c\u7f9f\u6c2f\u55b9\uff08HCQ\uff09\u3002 HCQ \u88ab\u6279\u51c6\u7528\u4e8e\u6cbb\u7597\u7c7b\u98ce\u6e7f\u6027\u5173\u8282\u708e\uff0c\u5e76\u88ab\u5927\u91cf\u60a3\u6709\u8be5\u75be\u75c5\u7684\u60a3\u8005\u4f7f\u7528\u3002 \u636e\u62a5\u9053\uff0c\u8bb8\u591a\u4eba\u8fd8\u4f7f\u7528\u975e cGMP \u7ea7 CBD \u6765\u6539\u5584\u4ed6\u4eec\u7684\u75c7\u72b6\u3002 Incannex \u7684\u76ee\u7684\u662f\u5bf9\u5176\u4e13\u6709\u7684 HCQ \u548c CBD \u56fa\u5b9a\u5242\u91cf\u7ec4\u5408\u8fdb\u884c\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u4ee5\u83b7\u5f97\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40\uff08 FDA \uff09\u5bf9\u836f\u7269\u7ea7 IHL-675A \u4ea7\u54c1\u7684\u8425\u9500\u6279\u51c6\uff0c\u60a3\u8005\u7684\u533b\u751f\u53ef\u4ee5\u653e\u5fc3\u5f00\u5904\u65b9 . \u5728\u8fdb\u884c\u6b64 2 \u671f\u8bd5\u9a8c\u4e4b\u524d\uff0c\u636e\u62a5\u9053 IHL-675A \u5728 1 \u671f\u8bd5\u9a8c\u4e2d\u5177\u6709\u826f\u597d\u7684\u8010\u53d7\u6027\u3002 \u5728\u52a8\u7269\u7814\u7a76\u4e2d\uff0c\u89c2\u5bdf\u5230 IHL-675A… Continue reading Incannex \u5f00\u59cb\u8bc4\u4f30 IHL-675A \u6cbb\u7597\u7c7b\u98ce\u6e7f\u6027\u5173\u8282\u708e\u7684 2 \u671f\u8bd5\u9a8c<\/span><\/a><\/p>\n","protected":false},"author":4,"featured_media":18508,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[33],"yoast_head":"\nIncannex \u5f00\u59cb\u8bc4\u4f30 IHL-675A \u6cbb\u7597\u7c7b\u98ce\u6e7f\u6027\u5173\u8282\u708e\u7684 2 \u671f\u8bd5\u9a8c<\/title>\n<meta name=\"description\" content=\"\u836f\u7528\u5927\u9ebb\u7d20\u548c\u8ff7\u5e7b\u7597\u6cd5\u5f00\u53d1\u5546 Incannex Healthcare (ASX: IHL) \u5df2\u7ecf\u5f00\u59cb\u4e86\u4e00\u9879 2 \u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u4ee5\u8bc4\u4f30\u5176\u4e13\u6709\u6297\u708e\u8054\u5408\u836f\u7269 IHL-675A \u5728\u7c7b\u98ce\u6e7f\u6027\u5173\u8282\u708e\u60a3\u8005\u4e2d\u7684\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Incannex \u5f00\u59cb\u8bc4\u4f30 IHL-675A \u6cbb\u7597\u7c7b\u98ce\u6e7f\u6027\u5173\u8282\u708e\u7684 2 \u671f\u8bd5\u9a8c\" \/>\n<meta property=\"og:description\" content=\"\u836f\u7528\u5927\u9ebb\u7d20\u548c\u8ff7\u5e7b\u7597\u6cd5\u5f00\u53d1\u5546 Incannex Healthcare (ASX: IHL) \u5df2\u7ecf\u5f00\u59cb\u4e86\u4e00\u9879 2 \u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u4ee5\u8bc4\u4f30\u5176\u4e13\u6709\u6297\u708e\u8054\u5408\u836f\u7269 IHL-675A \u5728\u7c7b\u98ce\u6e7f\u6027\u5173\u8282\u708e\u60a3\u8005\u4e2d\u7684\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/incannex-commences-phase-2-trial-ihl-675a-treatment-rheumatoid-arthritis\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-27T22:27:35+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T17:57:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/Incannex-Healthcare-ASX-IHL-Phase-2-trial-IHL-675A-treatment-rheumatoid-arthritis-hydroxychloroquine-cannabidiol.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Imelda Cotton\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Imelda Cotton\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/incannex-commences-phase-2-trial-ihl-675a-treatment-rheumatoid-arthritis\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/incannex-commences-phase-2-trial-ihl-675a-treatment-rheumatoid-arthritis\/\",\"name\":\"Incannex \u5f00\u59cb\u8bc4\u4f30 IHL-675A \u6cbb\u7597\u7c7b\u98ce\u6e7f\u6027\u5173\u8282\u708e\u7684 2 \u671f\u8bd5\u9a8c\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2023-02-27T22:27:35+00:00\",\"dateModified\":\"2023-08-29T17:57:08+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e\"},\"description\":\"\u836f\u7528\u5927\u9ebb\u7d20\u548c\u8ff7\u5e7b\u7597\u6cd5\u5f00\u53d1\u5546 Incannex Healthcare (ASX: IHL) \u5df2\u7ecf\u5f00\u59cb\u4e86\u4e00\u9879 2 \u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u4ee5\u8bc4\u4f30\u5176\u4e13\u6709\u6297\u708e\u8054\u5408\u836f\u7269 IHL-675A \u5728\u7c7b\u98ce\u6e7f\u6027\u5173\u8282\u708e\u60a3\u8005\u4e2d\u7684\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/incannex-commences-phase-2-trial-ihl-675a-treatment-rheumatoid-arthritis\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/incannex-commences-phase-2-trial-ihl-675a-treatment-rheumatoid-arthritis\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/incannex-commences-phase-2-trial-ihl-675a-treatment-rheumatoid-arthritis\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Incannex \u5f00\u59cb\u8bc4\u4f30 IHL-675A \u6cbb\u7597\u7c7b\u98ce\u6e7f\u6027\u5173\u8282\u708e\u7684 2 \u671f\u8bd5\u9a8c\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e\",\"name\":\"Imelda Cotton\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g\",\"caption\":\"Imelda Cotton\"},\"description\":\"Imelda Cotton has over 20 years experience as a journalist and communications professional. She has spent the bulk of her career in the resources sector, having also worked directly with oil and gas majors and as a journalist covering a vast array of ASX listed companies within the resources, energy, science and health sectors.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=4\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Incannex \u5f00\u59cb\u8bc4\u4f30 IHL-675A \u6cbb\u7597\u7c7b\u98ce\u6e7f\u6027\u5173\u8282\u708e\u7684 2 \u671f\u8bd5\u9a8c","description":"\u836f\u7528\u5927\u9ebb\u7d20\u548c\u8ff7\u5e7b\u7597\u6cd5\u5f00\u53d1\u5546 Incannex Healthcare (ASX: IHL) \u5df2\u7ecf\u5f00\u59cb\u4e86\u4e00\u9879 2 \u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u4ee5\u8bc4\u4f30\u5176\u4e13\u6709\u6297\u708e\u8054\u5408\u836f\u7269 IHL-675A \u5728\u7c7b\u98ce\u6e7f\u6027\u5173\u8282\u708e\u60a3\u8005\u4e2d\u7684\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Incannex \u5f00\u59cb\u8bc4\u4f30 IHL-675A \u6cbb\u7597\u7c7b\u98ce\u6e7f\u6027\u5173\u8282\u708e\u7684 2 \u671f\u8bd5\u9a8c","og_description":"\u836f\u7528\u5927\u9ebb\u7d20\u548c\u8ff7\u5e7b\u7597\u6cd5\u5f00\u53d1\u5546 Incannex Healthcare (ASX: IHL) \u5df2\u7ecf\u5f00\u59cb\u4e86\u4e00\u9879 2 \u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u4ee5\u8bc4\u4f30\u5176\u4e13\u6709\u6297\u708e\u8054\u5408\u836f\u7269 IHL-675A \u5728\u7c7b\u98ce\u6e7f\u6027\u5173\u8282\u708e\u60a3\u8005\u4e2d\u7684\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/incannex-commences-phase-2-trial-ihl-675a-treatment-rheumatoid-arthritis\/","og_site_name":"smallcapsCN","article_published_time":"2023-02-27T22:27:35+00:00","article_modified_time":"2023-08-29T17:57:08+00:00","og_image":[{"width":640,"height":400,"url":"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/Incannex-Healthcare-ASX-IHL-Phase-2-trial-IHL-675A-treatment-rheumatoid-arthritis-hydroxychloroquine-cannabidiol.jpg","type":"image\/jpeg"}],"author":"Imelda Cotton","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Imelda Cotton"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/incannex-commences-phase-2-trial-ihl-675a-treatment-rheumatoid-arthritis\/","url":"https:\/\/smallcapscn.x5view.co\/incannex-commences-phase-2-trial-ihl-675a-treatment-rheumatoid-arthritis\/","name":"Incannex \u5f00\u59cb\u8bc4\u4f30 IHL-675A \u6cbb\u7597\u7c7b\u98ce\u6e7f\u6027\u5173\u8282\u708e\u7684 2 \u671f\u8bd5\u9a8c","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2023-02-27T22:27:35+00:00","dateModified":"2023-08-29T17:57:08+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e"},"description":"\u836f\u7528\u5927\u9ebb\u7d20\u548c\u8ff7\u5e7b\u7597\u6cd5\u5f00\u53d1\u5546 Incannex Healthcare (ASX: IHL) \u5df2\u7ecf\u5f00\u59cb\u4e86\u4e00\u9879 2 \u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u4ee5\u8bc4\u4f30\u5176\u4e13\u6709\u6297\u708e\u8054\u5408\u836f\u7269 IHL-675A \u5728\u7c7b\u98ce\u6e7f\u6027\u5173\u8282\u708e\u60a3\u8005\u4e2d\u7684\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/incannex-commences-phase-2-trial-ihl-675a-treatment-rheumatoid-arthritis\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/incannex-commences-phase-2-trial-ihl-675a-treatment-rheumatoid-arthritis\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/incannex-commences-phase-2-trial-ihl-675a-treatment-rheumatoid-arthritis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"Incannex \u5f00\u59cb\u8bc4\u4f30 IHL-675A \u6cbb\u7597\u7c7b\u98ce\u6e7f\u6027\u5173\u8282\u708e\u7684 2 \u671f\u8bd5\u9a8c"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e","name":"Imelda Cotton","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g","caption":"Imelda Cotton"},"description":"Imelda Cotton has over 20 years experience as a journalist and communications professional. She has spent the bulk of her career in the resources sector, having also worked directly with oil and gas majors and as a journalist covering a vast array of ASX listed companies within the resources, energy, science and health sectors.","url":"https:\/\/smallcapscn.x5view.co\/?author=4"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/6487"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=6487"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/6487\/revisions"}],"predecessor-version":[{"id":20285,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/6487\/revisions\/20285"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/18508"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=6487"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=6487"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=6487"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}